Beacon Therapeutics Is An Ophthalmic Gene Therapy Company Based In Alachuafloridafounded In 2023With Around 70 Employeesthe Company Is Dedicated To Developing Treatments For Both Prevalent And Rare Retinal Diseases That Lead To Blindnesssuch As X Linked Retinitis Pigmentosaxlrp Dry Age Related Macular Degenerationdamd And Cone Rod Dystrophycrd The Company Emerged From The Rebranding Of Applied Genetic Technologies Corpagtcand Focuses On Restoring Vision Through Gene Therapy Using Adeno Associated Virusaavtechnologybeacon S Lead Candidateagtc 501Is Currently In A Phase Ii Registrational Trial For Xlrpthe Company Is Also Advancing Preclinical Programs For Crd And Damdbeacon Collaborates With Academic Institutions And Has Secured Significant Funding To Support Its Clinical And Preclinical Initiatives
